As expected, the Ki-67 level in the HB tumor tissues of nude mice treated with Remodelin was significantly reduced, suggesting that the NAT10 inhibitor has good therapeutic potential in vivo (Fig. 7H). Here, NAT10 is linked to hemoglobin measurement.